5 July 2022
-
MRD - What will change in the next year?
Multiple Myeloma~myelomaconnect~NDMM~RRMM
EM-93560
Myeloma Connect
20 September 2022
-
The role of the multidisciplinary team in the management of patients with AL amyloidosis
Amyloidosis~Multiple Myeloma~myelomaconnect
EM-93566
4 October 2022
-
How do we ensure we choose the right treatment for the right patient?
Multiple Myeloma~myelomaconnect~NDMM
EM-93604
25 October 2022
-
What are the key drivers for selecting ideal RRMM patients for treatment with bispecific antibodies?
Multiple Myeloma~myelomaconnect~RRMM
EM-93607
15 November 2022
-
A focus on standard risk patients with MM and the roadmap to cure
Multiple Myeloma~myelomaconnect~NDMM
EM-93617
16 November 2022
-
What are the key drivers for selecting ideal RRMM patients for treatment with CAR T-cell therapy?
Multiple Myeloma~myelomaconnect~RRMM
EM-93624
19 May 2022
-
47 Minutes
Bispecific antibodies: raising new horizons for RRMM?
myelomaconnect~RRMM
EM-88730
12 May 2022
-
48 Minutes
Practical considerations around CAR T-cell therapies for patients with multiple myeloma
MM~Multiple Myeloma~myelomaconnect~RRMM
EM-78417
10 May 2022
-
46 Minutes
Bridging the gap between patient and clinician perspectives in myeloma care
MM~Multiple Myeloma~myelomaconnect~NDMM~RRMM
EM-78406
28 April 2022
-
45 Minutes
How do you plan the patient journey at diagnosis for patients with multiple myeloma?
MM~Multiple Myeloma~myelomaconnect~NDMM~RRMM
EM-78398